Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.

Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.
复制标题

DOI:
10.1084/jem.20202350
复制
发表时间:
2021-09-06
期刊:
The Journal of experimental medicine
影响因子:
--
通讯作者:
Yang ZJ
Yang ZJ
中科院分区:
其他
文献类型:
--
作者:
Guo D;Wang Y;Cheng Y;Liao S;Hu J;Du F;Xu G;Liu Y;Cai KQ;Cheung M;Wainwright BJ;Lu QR;Zhao Y;Yang ZJ

文献摘要

参考文献

被引文献

相似文献

BMP-Sox9信号驱动肿瘤细胞转分化为星形胶质细胞,这有助于sh驱动的髓母细胞瘤的复发,髓母细胞瘤是一种常见的儿童脑肿瘤。星形胶质细胞是大脑中主要的胶质细胞类型,在支持髓母细胞瘤(MB)的进展中起关键作用,髓母细胞瘤是最常见的儿童恶性脑肿瘤。通过谱系追踪分析和单细胞RNA测序,我们证明星形胶质细胞主要来源于复发MB(而不是原发性MB)中肿瘤细胞的转分化,尽管MB细胞通常被认为是神经元谱系的。MB细胞的这种转分化依赖于Sox9,这是一种对胶质细胞形成至关重要的转录因子。我们的研究进一步揭示了骨形态发生蛋白(BMPs)通过诱导Sox9的磷酸化来刺激MB细胞的转分化。药理抑制BMP信号可抑制MB细胞向星形胶质细胞的转分化,抑制肿瘤复发。我们的研究确定了原发性和复发性MB中星形胶质细胞的不同细胞来源,并为通过靶向肿瘤细胞转分化预防和治疗MB复发提供了途径。
BMP-Sox9 signaling drives tumor cells to transdifferentiate into astrocytes, which contributes to the recurrence of SHH-driven medulloblastoma, a common type of pediatric brain tumor. Astrocytes, a major glial cell type in the brain, play a critical role in supporting the progression of medulloblastoma (MB), the most common malignant pediatric brain tumor. Through lineage tracing analyses and single-cell RNA sequencing, we demonstrate that astrocytes are predominantly derived from the transdifferentiation of tumor cells in relapsed MB (but not in primary MB), although MB cells are generally believed to be neuronal-lineage committed. Such transdifferentiation of MB cells relies on Sox9, a transcription factor critical for gliogenesis. Our studies further reveal that bone morphogenetic proteins (BMPs) stimulate the transdifferentiation of MB cells by inducing the phosphorylation of Sox9. Pharmacological inhibition of BMP signaling represses MB cell transdifferentiation into astrocytes and suppresses tumor relapse. Our studies establish the distinct cellular sources of astrocytes in primary and relapsed MB and provide an avenue to prevent and treat MB relapse by targeting tumor cell transdifferentiation.
他汀类药物与 Hedgehog 通路抑制剂协同治疗髓母细胞瘤
DOI: 10.1158/1078-0432.ccr-17-2923
发表时间: 2018-03-15
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Gordon RE;Zhang L;Peri S;Kuo YM;Du F;Egleston BL;Ng JMY;Andrews AJ;Astsaturov I;Curran T;Yang ZJ
通讯作者: Yang ZJ
DOI: 10.1101/gad.1017802
发表时间: 2002-11-01
影响因子: 10.5
作者:
Akiyama, H;Chaboissier, MC;de Crombrugghe, B
通讯作者: de Crombrugghe, B
DOI: 10.1038/s41586-019-1434-6
发表时间: 2019-08-01
期刊: NATURE
影响因子: 64.8
作者:
Hovestadt, Volker;Smith, Kyle S.;Northcott, Paul A.
通讯作者: Northcott, Paul A.
DOI: 10.1074/jbc.m705414200
发表时间: 2007-12-21
影响因子: 4.8
作者:
Alvarez-Rodiguez, Ruben;Barzi, Mercedes;Pons, Sebastian
通讯作者: Pons, Sebastian
DOI: 10.1016/j.neuron.2005.08.028
发表时间: 2005-10-06
期刊: NEURON
影响因子: 16.2
作者:
Machold, R;Fishell, G
通讯作者: Fishell, G